GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.320
+0.040 (1.75%)
At close: Apr 28, 2026, 4:00 PM EDT
2.340
+0.020 (0.86%)
After-hours: Apr 28, 2026, 7:39 PM EDT
GoodRx Holdings Revenue
In the year 2025, GoodRx Holdings had annual revenue of $796.85M with 0.57% growth. GoodRx Holdings had revenue of $194.79M in the quarter ending December 31, 2025, a decrease of -1.91%.
Revenue (ttm)
$796.85M
Revenue Growth
+0.57%
P/S Ratio
1.00
Revenue / Employee
$1,143,261
Employees
697
Market Cap
794.77M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.53B |
| Claritev | 965.41M |
| Phreesia | 480.59M |
| Certara | 418.84M |
| TruBridge | 346.84M |
| HealthStream | 304.06M |
| Omada Health | 260.21M |
| Schrödinger | 255.87M |
GDRX News
- 11 days ago - GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - Business Wire
- 13 days ago - GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market - Benzinga
- 13 days ago - GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price - Business Wire
- 19 days ago - GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide - Business Wire
- 6 weeks ago - GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications - Business Wire
- 7 weeks ago - GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® - Business Wire
- 2 months ago - GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers - PYMNTS
- 2 months ago - GoodRx Holdings Earnings Call Transcript: Q4 2025 - Transcripts